Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats

Journal of Psychopharmacology

Volumn 21, Issue 7, 2007, Pages 742-750

  Mattioli, Laura ^a   Perfumi, Marina ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Adaptogens; Anorexia; CRF; CRF induced anorexia; Fluoxetineinduced anorexia; LPS induced anorexia; Restraint; Rhodiola rosea; Stress induced anorexia

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; PHENOL DERIVATIVE; RHODIOLA ROSEA EXTRACT; ROSAVIN; SALIDROSID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; FEEDING; FOOD DEPRIVATION; FOOD INTAKE; HYPOPHAGIA; IMMOBILIZATION STRESS; MALE; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; RAT; REPEATED DRUG DOSE; STANDARD; WISTAR RAT;

ANIMALS; ANOREXIA; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEEDING BEHAVIOR; FLUOXETINE; GLUCOSIDES; IMMOBILIZATION; LIPOPOLYSACCHARIDES; MALE; PHENOLS; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; RHODIOLA; STRESS, PSYCHOLOGICAL;

EID: 34548770601     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106074064     Document Type: Article

References (63)

1. Abidov M., Crendal F., Grachev S., Seifulla R., Ziegenfuss T. (2003) Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med 136 (6). 585 - 587
2. Blundell J.E. (1986) Serotonin manipulations and the structure of feeding behaviour. Appetite 7 (suppl.). 39 - 56
3. Bradbury M J., McBurnie M I., Denton D A., Lee K F., Vale W W. (2000) Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology 141 (8). 2715 - 2724
4. Brown R.P., Gerbarg P.L., Ramazanov Z. (2002) Rhodiola rosea. A Phytomedicinal Overview. Herbal Gram 56: 40 - 52
5. Burchfield S.R. (1979) The stress response: a new perspective. Psychosom Med 41 (8). 661 - 672
6. Chaouloff F. (2000) Serotonin, stress and corticoids. J Psychopharmacol 14 (2). 139 - 151
7. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. (2001) Nocicetin/orphanin FQ inhibits stress and CRF-induced aorexia in rats. NeuroReport 12: 1145 - 1149
8. Contarino A., Dellu F., Koob G.F., Smith G.W., Lee K.F., Vale W.W., Gold L.H. (2000) Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141: 2698 - 2702
9. Currie P.J., Braver M., Mirza A., Sricharoon K. (2004) Sex differences in the reversal of fluoxetine-induced anorexia following raphe injections of 8-OH-DPAT. Psychopharmacology (Berl) 172 (4). 359 - 364
10. Dallman M F., Pecoraro N., Akana S F., La Fleur S E., Gomez F., Houshyar H., Bell M E., Bhatnagar S., Laugero K D., Manalo S. (2003) Chronic stress and obesity: a new view of 'comfort food '. Proc Natl Acad Sci USA 100 (20). 11696 - 11701
11. Darbinyan V., Kteyan A., Panossian A., Gabrielian E., Wikman G., Wagner H. (2000) Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 7 (5). 365 - 371
12. De Souza E B. (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20: 789 - 819
13. De Souza E B., Grigoriadis D E. (1994) Corticotropin-releasing factor: physiology, pharmacology and role in central nervous system and immune disorders. In Bloom F E, Kupfer D J (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 505 - 517
14. Dunn A.J. (1992 a) Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J Pharmacol Exp Ther 261 (3). 964 - 969
15. Dunn A.J. (1992 b) The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res Bull 29 (6). 807 - 812
16. Dunn A.J., Berridge C.W. (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15: 71 - 100
17. Erb S., Stewart J. (1999) A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19 (20). RC35
18. German C., Ramazanov Z., Bernard Suarez M (1999) Artic Root (Rodiola rosea). the powerful ginseng alternative. Kensington Publishing Corp., New York
19. Gonzalez M.M., Debilly G., Valatx J.L., Jouvet M.R. (1995) Sleep increase after immobilization stress: role of the noradrenergic locus coeruleus system in the rat. Neurosci Lett 202 (1 - 2). 5 - 8
20. Gross M.J., Kahn J.P., Laxenaire M., Nicolas J.P., Burlet C. (1994) Corticotropin-releasing factor and anorexia nervosa: reactions of the hypothalamus-pituitary-adrenal axis to neurotropic stress. Ann Endocrinol 55: 221 - 228
21. Heinrichs S.C., Koob G.F. (1992) Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats. Psychopharmacology 109: 177 - 184
22. Heinrichs S.C., Richard D (1999) The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behaviour. Neuropeptide 33 (5). 350 - 359
23. Hotta M., Shibasaki T., Arai K., Demura H. (1999) Corticotropin releasing factor receptor type 1 mediates emotional stress induced inhibition of food intake and behavioral changes in rats. Brain Res 823: 221 - 225
24. Hrupka B.J., Langhans W. (2001) A role for serotonin in lipopolysaccharide-induced anorexia in rats. Pharmacol Biochem Behav 68 (2). 355 - 362
25. Inoue K., Valdez G.R., Reyes T.M., Reinhardt L.E., Tabarin A., Rivier J., Vale W.W., Sawchenko P.E., Koob G.F., Zorrilla E.P. (2003) Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J Pharmacol Exp Ther 305 (1). 385 - 393
26. Kelly G.S. (2001) Rhodiola rosea: a possible plant adaptogen. Altern Med Rev 6 (3). 293 - 302
27. Koob G.F., Heinrichs S.C. (1999) A role for corticotropin realising factor and urocortin in behavioral responses to stressors. Brain Res 848: 141 - 152
28. Kurkin V.A., Zapesochnaya G.G. (1986) Chemical composition and pharmacological properties of Rhodiola rosea. Khim Pharm Zurnal 20: 1231 - 1244
29. Langhans W., Hrupka B. (1999) Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33 (5). 415 - 424
30. Langhans W., Harlacher R., Scharrer E. (1989) Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiol Behav 46: 535 - 539
31. Levine A.S., Rogers B., Kneip J., Grace M., Morley J.E. (1983) Effect of centrally administered corticotropin releasing factor (CRF) on multiple feeding paradigms. Neuropharmacology 22: 337 - 339
32. Lishmanov I B., Maslova L V., Maslov L N., Dan'shina E N. (1993) The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism. Biull Eksp Biol Med 116: 175 - 176
33. Lishmanov Iu B., Trifonova Zh V., Tsibin A N., Maslova L V., Dementeva L A. (1987) Plasma beta-endorphin and stress hormones in stress and adaptation. Biull Eksp Biol Med 103 (4). 422 - 424
34. Ma S., Morilak D.A. (2005) Norepinephrine release in medial amygdala facilitates activation of the hypothalamic-pituitary-adrenal axis in response to acute immobilisation stress. J Neuroendocrinol 17 (1). 22 - 28
35. Maslova L V., Kondrat'ev B I., Maslov L N., Lishmanov I B. (1994) The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksp Klin Farmakol 57: 61 - 63
36. MohanKumar S M., MohanKumar P S., Quadri S K. (1999) Lipopolysaccharide- induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Res 824 (2). 232 - 237
37. Morley J.E. (1987) Neuropeptide regulation of appetite and weight. Endocrine Rev 8: 256 - 257
38. Morley J.E., Levine A.S. (1982) Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci 31: 1459 - 1464
39. Panossian A. (2003) Adaptogens: tonic herbs for fatigue and stress. Alt Comp Ther 9: 327 - 332
40. Panossian A., Wagner H. (2005) Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19: 819 - 838
41. Panossian A., Wikman G., Wagner H. (1999) Plant adaptogens III. Earlier and more recent aspects and concepts on their mode of actions. Phytomedicine 6: 287 - 300
42. Paxinos G., Watson C. (1998) The rat brain in stereotaxic coordinates. 4 th edn. Academic Press, San Diego
43. Perfumi M., Mattioli L. (2006) Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytotherapy Research (in press)
44. Plata-Salaman C R. (1991) Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev 15 (2). 243 - 258
45. Plata-Salaman C R. (1998) Cytokines and feeding. News Physiol Sci. 13: 298 - 304
46. Plata-Salaman C R. (2001) Cytokines and feeding. Int J Obes Relat Metab Disord 25 (suppl. 5). S48 - S52
47. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843 - 2848
48. Richard D. (1993) Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann NY Acad Sci 697: 155 - 172
49. Romero L., Artigas F. (1997) Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway-role of somatodendritic autoreceptors. J Neurochem 63: 2593 - 2603
50. Saratikov A.S., Krasnov E.A. (1987) Rhodiola rosea is a valuable medicinal plant (Golden Root). Tomsk State University Press, Russia
51. Schulkin J., McEwen B S., Gold P W. (1994) Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 18: 385 - 396
52. Sekino A., Ohata H., Mano-Otagiri A., Arai K., Shibasaki T. (2004) Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology (Berl) 176 (1). 30 - 38
53. Shevtsov V A., Zholus B I., Shervarly V I., Vol'skij V B., Korovin Y P., Khristich M P., Roslyakova N A., Wikman G. (2003) A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 10 (2-3). 95 - 105
54. Spasov A.A., Wikman G.K., Mandrikov V.B., Mironova I.A., Neumoin V.V. (2000) A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7 (2). 85 - 89
55. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., Koob G.F. (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561 - 1564
56. Swiergiel A.H., Dunn A.J. (1999) CRF-deficient mice respond like wild-type mice to hypophagic stimuli. Pharmacol Biochem Behav 64: 59 - 64
57. Trillat A.C., Malagie I., Mathe-Allainmat M., Anmella M.C., Jacquot C., Langlois M., Gardier A.M. (1998) Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists. Eur J Pharmacol 357 (2 - 3). 179 - 184
58. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. (1989) Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am J Physiol 257: R613 - R617
59. Wagner H., Norr H., Winterhoff H. (1994) Plant adaptogens. Phytomedicine 1: 63 - 76
60. Wang S., You X.T., Wang F.P. (1992) [HPLC determination of salidroside in the roots of Rhodiola genus plants]. Yao Xue Xue Pao 27 (11). 849 - 852
61. Yoshikawa M., Shimada H., Shimoda H., Murakami N., Yamahara J., Matsuda H. (1996) Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. (Crassulaceae). Chem Pharm Bull (Tokyo) 44 (11). 2086 - 2091
62. Zhu B.W., Sun Y.M., Yun X., Han S., Piao M.L., Murata Y., Tada M. (2003) Reduction of noise-stress-induced physiological damage by radices of Astragali and Rhodiolae: glycogen, lactic acid and cholesterol contents in liver of the rat. Biosci Biotechnol Biochem 67 (9). 1930 - 1936
63. Zorrilla E.P., Koob G.F. (2004) The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13 (7). 799 - 828